ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 194 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $2,273,000 | -17.6% | 26,600 | +11.8% | 0.02% | -21.4% |
| Q2 2018 | $2,758,000 | +46.9% | 23,800 | +2.6% | 0.03% | +40.0% |
| Q1 2018 | $1,877,000 | +36.4% | 23,200 | -1.1% | 0.02% | +33.3% |
| Q4 2017 | $1,376,000 | +91.1% | 23,450 | +17.2% | 0.02% | +66.7% |
| Q2 2017 | $720,000 | +16.9% | 20,000 | 0.0% | 0.01% | +28.6% |
| Q1 2017 | $616,000 | -8.1% | 20,000 | 0.0% | 0.01% | -22.2% |
| Q4 2016 | $670,000 | +25.9% | 20,000 | 0.0% | 0.01% | +12.5% |
| Q3 2016 | $532,000 | +20.6% | 20,000 | 0.0% | 0.01% | +14.3% |
| Q2 2016 | $441,000 | -24.9% | 20,000 | 0.0% | 0.01% | -30.0% |
| Q1 2016 | $587,000 | -11.1% | 20,000 | 0.0% | 0.01% | -16.7% |
| Q4 2015 | $660,000 | – | 20,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
| GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
| ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
| Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
| Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
| Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
| 361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
| ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
| AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |